Possible modulation of glycated protein levels in prehypertension by lipid peroxides

Clinical and Experimental Hypertension

Volumn 34, Issue 7, 2012, Pages 517-522

  Nambiar, Selvaraj ^a   Viswanathan, Sathiyapriya ^a   Zachariah, Bobby ^a   Hanumanthappa, Nandeesha ^a   Agrawal, Aparna ^a   Nadaradjan, Rattina Dasse ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Fructosamine; Glycated hemoglobin; Malondialdehyde; Oxidative stress; Prehypertension

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED PROTEIN; HEMOGLOBIN A1C; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; LIPID PEROXIDATION; MALE; PREHYPERTENSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS;

ADULT; CASE-CONTROL STUDIES; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; MIDDLE AGED; PREHYPERTENSION;

EID: 84870407086     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.681721     Document Type: Article

References (42)

1. Chobanian AV, Bakris GR, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
2. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682-1686.
3. Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend to high prevalence of hypertension in a developing country. Int J Med Sci 2005; 2:70-78.
4. Thornalley PJ. Clinical significance of glycation. Clin Lab 1999; 45:263-273.
5. Lapolla A, Traldi P, Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 2005; 38:103-115.
6. Mayer TK, Freedman ZR. Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility. Clin Chim Acta 1983; 127:147-184.
7. Chowdhury TA, Lasker SS. Elevated glycated hemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998; 74:480-481.
8. Selvaraj N, Bobby Z, Sridhar MG. Increased glycation of hemoglobin in chronic renal failure: potential role of oxidative stress. Arch Med Res 2008; 39:277-284.
9. Nilsson PM, Lind L, Pollare T, Berne C, Litthell HO. Increased concentration of hemoglobin A1C, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 1995; 44:557-561.
10. Coban E, OzdoganM, Timuragaoglu A. Effect of iron deficiency anemia on the concentrations of hemoglobin A1C in nondiabetic patients. Acta Haematol 2004; 112:126-128.
11. Cecchin E, De Marchi S, Panarello G, De Angelis V. Rheological abnormalities of erythrocyte deformability and increased glycosylation of hemoglobin in nephrotic syndrome. Am J Nephrol 1987; 7:18-21.
12. Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuno J. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal failure. Am J Nephrol 1991; 11:37-43.
13. Rodriguez-Garcia J, Requena JR, Rodriguez-Segade S. Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin Chem 1998; 44:250-255.
14. Roberts RN, Traub AI, Kennedy AL, Hadden DR. Glycosylated haemoglobin and hypertension arising in pregnancy. Br J Obest Gynaecol 1998; 105:1122-1124.
15. Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Agrawal A, Pavithran P. Enhanced glycation of hemoglobin and plasma proteins is associated with increased lipid peroxides levels in non-diabetic hypertensive subjects. Arch Med Res 2007; 38:822-826.
16. Jain SK, Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 1997; 22:593-596.
17. Selvaraj N, Bobby Z, Sridhar MG. Oxidative stress: does it play a role in the genesis of early glycated proteins? Med Hypotheses 2008; 70:265-268.
18. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta 2005; 366:190-195.
19. Wang X, Desai K, Juurlink BH, de Champlain J, Wu L. Genderrelated differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. Kidney Int 2006; 69:281-287.
20. Wu L, Juurlink BH. Increased methylglyoxal and oxidative stress in hypertensive rat vascuale smooth muscle cells. Hypertension 2002; 39:809-814.
21. Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 2005; 23:1565-1573.
22. Satoh K. Serum lipid peroxide in cardiovascular disorder determined by a new colorimetric method. Clin Chim Acta 1978; 90:37-43.
23. O. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47:412-426.
24. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Economou M, Papadimitriou L, Stefanadis C. The association between pre-hypertension status and oxidative stress markers related to atherosclerosis disease: the ATTICA study. Atherosclerosis 2007; 192:169-176.
25. Sathiyapriya V, Nandeesha H, Bobby Z, Selvaraj N, Pavithran P. Perturbation of oxidant-antioxidant status in non-obese prehypertensive male subjects. J Hum Hypertens 2007; 21:176-178.
26. Kedziora-Kornatowska K, Czuczejko J, PawlukH,Kornatowski T, Motyl J, Szadujkis-Szadurski L, Szewczyk-Golec K, Kedziora J. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 2004; 9:635-641.
27. Tandon R, Sinha MK, Garg H, Khanna R, Khanna HD. Oxidative stress in patients with essential hypertension. Natl Med J India 2005; 18:297-299.
28. Parslow RA, Sachdev P, Salonikas C, Lux O, Jorm AF, Naidoo D. Association between plasma antioxidants and hypertension in a community based sample of 415 Australians aged 60-64. J Hum Hypertens 2005; 19:219-226.
29. Armbruster DA. Fructosamine: structure, analysis and clinical usefulness. Clin Chem 1987; 33:2153-2163.
30. Slatter AD, Murray M, Bailey AJ. Formation of a dihydropyridine derivative as a potential cross-link from malondialdehyde in physiological systems. FEBS Lett 1998; 421:180-184.
31. Slattter AD, Bolton CS, Bailey AJ. The importance of lipidderived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43:550-557.
32. Nair V, Viettri DE, Cooper CS. Degenerative chemistry of malondialdehyde - structure, stereochemistry, and kinetics of formation of enaminals from reaction with amino acids. J AmChem Soc 1981; 103:3030-3036.
33. Sathiyapriya V, Nandeesha H, Bobby Z, Pavithran P, Selvaraj N, Dasse NR. Insulin resistance and enhanced protein glycation in men with prehypertension. Clin Chem Lab Med 2006; 44:1457-1461.
34. Kanauchi M, Kanauchi K, Hashimoto T, Saito Y. Metabolic syndrome and new category "pre-hypertension" in a Japanese population. Curr Med Res Opin 2004; 20:1365-1370.
35. Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Aparna A, Pavithran P. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk. Clin Exp Hypertens 2008; 30:367-374.
36. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992; 20:38-45.
37. Wenger NK. Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis 2003; 46:199-229.
38. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertens 1995; 25:155-161.
39. Sharret AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoprotein A-1 and B and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104:1108-1113.
40. Szapary PO, Rader DJ. The triglyceride-high-density lipoprotein axis: an important target of therapy? Am Heart J 2004; 148:211-221.
41. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Rad Biol Med 2000; 28:1685-1696.
42. Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med 1995; 46:223-234.